Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,634 | -8,772 | -6,578 | -4,704 | -2,185 |
| Depreciation Amortization | 37 | 201 | 161 | 121 | 81 |
| Accounts payable and accrued liabilities | N/A | -133 | N/A | N/A | N/A |
| Other Working Capital | -769 | -296 | -396 | -96 | -479 |
| Other Operating Activity | 108 | 859 | 456 | 398 | 191 |
| Operating Cash Flow | $-2,257 | $-8,142 | $-6,357 | $-4,282 | $-2,392 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,503 | 10,580 | 7,890 | 4,898 | 4,449 |
| Financing Cash Flow | $2,503 | $10,580 | $7,890 | $4,898 | $4,449 |
| Exchange Rate Effect | -15 | -2 | -17 | -8 | -4 |
| Beginning Cash Position | 4,678 | 2,241 | 2,241 | 2,241 | 2,241 |
| End Cash Position | 4,909 | 4,678 | 3,758 | 2,850 | 4,294 |
| Net Cash Flow | $231 | $2,437 | $1,517 | $609 | $2,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,257 | -8,142 | -6,357 | -4,282 | -2,392 |
| Free Cash Flow | -2,257 | -8,142 | -6,357 | -4,282 | -2,392 |